Bavarian enters monkeypox supply deal with Latin America and the Caribbean
The latest vaccine agreement has already been included in the Danish drugmaker’s full-year expectations, which are therefore maintained.
by marketwire, translated by daniel pedersen
Bavarian Nordic has entered a supply agreement with the Pan American Health Organization (PAHO), a regional office for the World Health Organization (WHO) and specialized health agency to the Americas, the Danish drugmaker announced in a press release on Wednesday, the same day it revealed its half-year 2022 financial results.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bavarian Nordic's reports revenue growth but books deficit
For subscribers
